The Oncosearch | Oncotarget

Th1^high in tumor microenvironment is an indicator of poor prognosis for patients with NSCLC Research Paper

Huang Jian, Shen Fangrong, Huang Haitao, Ling Chunhua, Zhang Guangbo

Published Jan 3, 2017 · Vol. 8, No. 8 · pp. 13116-13125

Prognostic impact of immune microenvironment in laryngeal and pharyngeal squamous cell carcinoma: Immune cell subtypes, immuno-suppressive pathways and clinicopathologic characteristics Research Paper

Georgia Karpathiou, Francois Casteillo, Jean-Baptiste Giroult, Fabien Forest, Pierre Fournel, Alessandra Monaya, Marios Froudarakis, Jean Marc Dumollard, Jean Michel Prades, Michel Peoc'h

Published Dec 27, 2016 · Vol. 8, No. 12 · pp. 19310-19322

Lymphocyte-to-monocyte ratio is associated with prognosis of diffuse large B-cell lymphoma: correlation with CD163 positive M2 type tumor-associated macrophages, not PD-1 positive tumor-infiltrating lymphocytes Research Paper

Jingxuan Wang, Kun Gao, Wanting Lei, Lina Dong, Qijia Xuan, Meiyan Feng, Jinlu Wang, Xiangnan Ye, Tuan Jin, Zhongbai Zhang, Qingyuan Zhang

Published Dec 27, 2016 · Vol. 8, No. 3 · pp. 5414-5425

Independent prognostic role of PD-L1 expression in patients with esophageal squamous cell carcinoma Research Paper

Dongxian Jiang, Qi Song, Haixing Wang, Jie Huang, Hao Wang, Jun Hou, Xiaojing Li, Yifan Xu, Akesu Sujie, Haiying Zeng, Lijie Tan, Yingyong Hou

Published Dec 26, 2016 · Vol. 8, No. 5 · pp. 8315-8329

Targeting cancer stem cell propagation with palbociclib, a CDK4/6 inhibitor: Telomerase drives tumor cell heterogeneity Research Paper

Gloria Bonuccelli, Maria Peiris-Pages, Bela Ozsvari, Ubaldo E. Martinez-Outschoorn, Federica Sotgia, Michael P. Lisanti

Published Dec 25, 2016 · Vol. 8, No. 6 · pp. 9868-9884

Antitumor effect of an adeno-associated virus expressing apolipoprotein A-1 fused to interferon alpha in an interferon alpha-resistant murine tumor model Research Paper

Marcos Vasquez, Vladimir Paredes-Cervantes, Fernando Aranda, Nuria Ardaiz, Celia Gomar, Pedro Berraondo

Published Dec 23, 2016 · Vol. 8, No. 3 · pp. 5247-5255

Prognostic value and clinicopathological features of PD-1/PD-L1 expression with mismatch repair status and desmoplastic stroma in Chinese patients with pancreatic cancer Research Paper

Yu Wang, Jiacheng Lin, Jiujie Cui, Ting Han, Feng Jiao, Zhuo Meng, Liwei Wang

Published Dec 21, 2016 · Vol. 8, No. 6 · pp. 9354-9365

MicroRNA expressing profiles in A53T mutant alpha-synuclein transgenic mice and Parkinsonian Research Paper

Mingshu Mo, Yousheng Xiao, Shuxuan Huang, Luan Cen, Xiang Chen, Limin Zhang, Qin Luo, Shaomin Li, Xinling Yang, Xian Lin, Pingyi Xu

Published Dec 11, 2016 · Vol. 8, No. 1 · pp. 15-28

PD-1 and its ligands are important immune checkpoints in cancer Research Paper

Yinan Dong, Qian Sun, Xinwei Zhang

Published Dec 10, 2016 · Vol. 8, No. 2 · pp. 2171-2186

Targeting of interleukin (IL)-17A inhibits PDL1 expression in tumor cells and induces anticancer immunity in an estrogen receptor-negative murine model of breast cancer Research Paper

Yun-Feng Ma, Chen Chen, Dongqing Li, Min Liu, Zhuang-Wei Lv, Yanhong Ji, Jiru Xu

Published Dec 7, 2016 · Vol. 8, No. 5 · pp. 7614-7624

Higher programmed cell death 1 ligand 1 (PD-L1) mRNA level in clear cell renal cell carcinomas is associated with a favorable outcome due to the active immune responses in tumor tissues Research Paper

Xiang-hui Ning, Yan-qing Gong, Shi-ming He, Teng Li, Jiang-yi Wang, Shuang-he Peng, Jin-chao Chen, Jia-yuan Liu, Nie-nie Qi, Ying-lu Guo, Kan Gong

Published Dec 1, 2016 · Vol. 8, No. 2 · pp. 3355-3363

IL-10 expression defines an immunosuppressive dendritic cell population induced by antitumor therapeutic vaccination Research Paper

Diana Llopiz, Marta Ruiz, Stefany Infante, Lorea Villanueva, Leyre Silva, Sandra Hervas-Stubbs, Diego Alignani, Elizabeth Guruceaga, Juan J. Lasarte, Pablo Sarobe

Published Dec 1, 2016 · Vol. 8, No. 2 · pp. 2659-2671

Robust detection of immune transcripts in FFPE samples using targeted RNA sequencing Research Paper

Benjamin E. Paluch, Sean T. Glenn, Jeffrey M. Conroy, Antonios Papanicolau-Sengos, Wiam Bshara, Angela R. Omilian, Elizabeth Brese, Mary Nesline, Blake Burgher, Jonathan Andreas, Kunle Odunsi, Kevin Eng, Ji He, Maochun Qin, Mark Gardner, Lorenzo Galluzzi, Carl D. Morrison

Published Nov 29, 2016 · Vol. 8, No. 2 · pp. 3197-3205

Toxicity profile of approved anti-PD-1 monoclonal antibodies in solid tumors: a systematic review and meta-analysis of randomized clinical trials Review

Ricardo Costa, Benedito A. Carneiro, Mark Agulnik, Alfred W. Rademaker, Sachin G. Pai, Victoria M. Villaflor, Massimo Cristofanilli, Jeffrey A. Sosman, Francis J. Giles

Published Nov 11, 2016 · Vol. 8, No. 5 · pp. 8910-8920

Magic year for multiple myeloma therapeutics: Key takeaways from the ASH 2015 annual meeting Review

Kejie Zhang, Aakash Desai, Dongfeng Zeng, Tiejun Gong, Peihua Lu, Michael Wang

Published Nov 11, 2016 · Vol. 8, No. 6 · pp. 10748-10759

Squamous cell carcinomas escape immune surveillance via inducing chronic activation and exhaustion of CD8⁺ T Cells co-expressing PD-1 and LAG-3 inhibitory receptors Research Paper

Ameet K. Mishra, Tanya Kadoishi, Xiaoguang Wang, Emily Driver, Zhangguo Chen, Xiao-Jing Wang, Jing H. Wang

Published Nov 9, 2016 · Vol. 7, No. 49 · pp. 81341-81356

PD-L1 promoter methylation is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients following radical prostatectomy Research Paper

Heidrun Gevensleben, Emily Eva Holmes, Diane Goltz, JÃ¶rn Dietrich, Verena Sailer, JÃ¶rg Ellinger, Dimo Dietrich, Glen Kristiansen

Published Nov 7, 2016 · Vol. 7, No. 48 · pp. 79943-79955

SCIB1, a huIgG1 antibody DNA vaccination, combined with PD-1 blockade induced efficient therapy of poorly immunogenic tumors Research Paper

Wei Xue, Victoria A. Brentville, Peter Symonds, Katherine W. Cook, Hideo Yagita, Rachael L. Metheringham, Lindy G. Durrant

Published Nov 4, 2016 · Vol. 7, No. 50 · pp. 83088-83100

PD 0332991, a selective cyclin D kinase 4/6 inhibitor, sensitizes lung cancer cells to treatment with epidermal growth factor receptor tyrosine kinase inhibitors Research Paper

Minghui Liu, Song Xu, Yuli Wang, Ying Li, Yongwen Li, Hongbing Zhang, Hongyu Liu, Jun Chen

Published Nov 4, 2016 · Vol. 7, No. 51 · pp. 84951-84964

A network meta-analysis on the efficacy of sixteen targeted drugs in combination with chemotherapy for treatment of advanced/metastatic colorectal cancer Research Paper

Dan-Zeng Ba-Sang, Zi-Wen Long, Hao Teng, Xu-Peng Zhao, Jian Qiu, Ming-Shan Li

Published Oct 31, 2016 · Vol. 7, No. 51 · pp. 84468-84479

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Th1^high in tumor microenvironment is an indicator of poor prognosis for patients with NSCLC Research Paper

Prognostic impact of immune microenvironment in laryngeal and pharyngeal squamous cell carcinoma: Immune cell subtypes, immuno-suppressive pathways and clinicopathologic characteristics Research Paper

Lymphocyte-to-monocyte ratio is associated with prognosis of diffuse large B-cell lymphoma: correlation with CD163 positive M2 type tumor-associated macrophages, not PD-1 positive tumor-infiltrating lymphocytes Research Paper

Independent prognostic role of PD-L1 expression in patients with esophageal squamous cell carcinoma Research Paper

Targeting cancer stem cell propagation with palbociclib, a CDK4/6 inhibitor: Telomerase drives tumor cell heterogeneity Research Paper

Antitumor effect of an adeno-associated virus expressing apolipoprotein A-1 fused to interferon alpha in an interferon alpha-resistant murine tumor model Research Paper

Prognostic value and clinicopathological features of PD-1/PD-L1 expression with mismatch repair status and desmoplastic stroma in Chinese patients with pancreatic cancer Research Paper

MicroRNA expressing profiles in A53T mutant alpha-synuclein transgenic mice and Parkinsonian Research Paper

PD-1 and its ligands are important immune checkpoints in cancer Research Paper

Targeting of interleukin (IL)-17A inhibits PDL1 expression in tumor cells and induces anticancer immunity in an estrogen receptor-negative murine model of breast cancer Research Paper

Higher programmed cell death 1 ligand 1 (PD-L1) mRNA level in clear cell renal cell carcinomas is associated with a favorable outcome due to the active immune responses in tumor tissues Research Paper

IL-10 expression defines an immunosuppressive dendritic cell population induced by antitumor therapeutic vaccination Research Paper

Robust detection of immune transcripts in FFPE samples using targeted RNA sequencing Research Paper

Toxicity profile of approved anti-PD-1 monoclonal antibodies in solid tumors: a systematic review and meta-analysis of randomized clinical trials Review

Magic year for multiple myeloma therapeutics: Key takeaways from the ASH 2015 annual meeting Review

Squamous cell carcinomas escape immune surveillance via inducing chronic activation and exhaustion of CD8⁺ T Cells co-expressing PD-1 and LAG-3 inhibitory receptors Research Paper

PD-L1 promoter methylation is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients following radical prostatectomy Research Paper

SCIB1, a huIgG1 antibody DNA vaccination, combined with PD-1 blockade induced efficient therapy of poorly immunogenic tumors Research Paper

PD 0332991, a selective cyclin D kinase 4/6 inhibitor, sensitizes lung cancer cells to treatment with epidermal growth factor receptor tyrosine kinase inhibitors Research Paper

A network meta-analysis on the efficacy of sixteen targeted drugs in combination with chemotherapy for treatment of advanced/metastatic colorectal cancer Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Th1high in tumor microenvironment is an indicator of poor prognosis for patients with NSCLC Research Paper

Prognostic impact of immune microenvironment in laryngeal and pharyngeal squamous cell carcinoma: Immune cell subtypes, immuno-suppressive pathways and clinicopathologic characteristics Research Paper

Lymphocyte-to-monocyte ratio is associated with prognosis of diffuse large B-cell lymphoma: correlation with CD163 positive M2 type tumor-associated macrophages, not PD-1 positive tumor-infiltrating lymphocytes Research Paper

Independent prognostic role of PD-L1 expression in patients with esophageal squamous cell carcinoma Research Paper

Targeting cancer stem cell propagation with palbociclib, a CDK4/6 inhibitor: Telomerase drives tumor cell heterogeneity Research Paper

Antitumor effect of an adeno-associated virus expressing apolipoprotein A-1 fused to interferon alpha in an interferon alpha-resistant murine tumor model Research Paper

Prognostic value and clinicopathological features of PD-1/PD-L1 expression with mismatch repair status and desmoplastic stroma in Chinese patients with pancreatic cancer Research Paper

MicroRNA expressing profiles in A53T mutant alpha-synuclein transgenic mice and Parkinsonian Research Paper

PD-1 and its ligands are important immune checkpoints in cancer Research Paper

Targeting of interleukin (IL)-17A inhibits PDL1 expression in tumor cells and induces anticancer immunity in an estrogen receptor-negative murine model of breast cancer Research Paper

Higher programmed cell death 1 ligand 1 (PD-L1) mRNA level in clear cell renal cell carcinomas is associated with a favorable outcome due to the active immune responses in tumor tissues Research Paper

IL-10 expression defines an immunosuppressive dendritic cell population induced by antitumor therapeutic vaccination Research Paper

Robust detection of immune transcripts in FFPE samples using targeted RNA sequencing Research Paper

Toxicity profile of approved anti-PD-1 monoclonal antibodies in solid tumors: a systematic review and meta-analysis of randomized clinical trials Review

Magic year for multiple myeloma therapeutics: Key takeaways from the ASH 2015 annual meeting Review

Squamous cell carcinomas escape immune surveillance via inducing chronic activation and exhaustion of CD8+ T Cells co-expressing PD-1 and LAG-3 inhibitory receptors Research Paper

PD-L1 promoter methylation is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients following radical prostatectomy Research Paper

SCIB1, a huIgG1 antibody DNA vaccination, combined with PD-1 blockade induced efficient therapy of poorly immunogenic tumors Research Paper

PD 0332991, a selective cyclin D kinase 4/6 inhibitor, sensitizes lung cancer cells to treatment with epidermal growth factor receptor tyrosine kinase inhibitors Research Paper

A network meta-analysis on the efficacy of sixteen targeted drugs in combination with chemotherapy for treatment of advanced/metastatic colorectal cancer Research Paper

Th1^high in tumor microenvironment is an indicator of poor prognosis for patients with NSCLC Research Paper

Squamous cell carcinomas escape immune surveillance via inducing chronic activation and exhaustion of CD8⁺ T Cells co-expressing PD-1 and LAG-3 inhibitory receptors Research Paper